With Lillian Robinson
In Regeneron Pharmaceuticals, Inc. v. Merus N.V., No. 2016-1346 (Fed. Cir. July 27, 2017), the Federal Circuit affirmed the district court's decision that the claims of U.S. Patent No. 8,502,018 were unenforceable...